NCT07800975

Brief Summary

The initial purpose of the study is to determine the true tomographic based age-specific prevalence of keratoconus among Danish patients with Downs Syndrome. If, as expected, the prevalence is sizeable, the next step is to determine the optimal age for screening - considering both sensitivity and specificity as well as the need for early diagnosis in order to preserve a good visual acuity with glasses. Lastly, the overall purpose based on the finding in the study is to evaluate if a tomographic screening program for keratoconus among patients with Downs syndrome is beneficial in Denmark. In addition, a sub-study will further have the purpose to investigate whether patients with Downs syndrome are using optimal correction. With the purpose of generating knowledge about refraction of this specific patient group - independent of whether they are diagnosed with keratoconus or not. The study will invite all persons with a genetic test either prenatal or postnatal showing trisomi 21 / Downs syndrom in Denmark and between the age og 10 and 20 years of age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 28, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
Last Updated

September 2, 2026

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

April 28, 2026

Last Update Submit

August 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corneal tomography

    Corneal tomography to determine if the participant has keratoconus or not

    Baseline, single time point when the study participants are included in the study

Study Arms (1)

Persons with Trisomi 21 / Downs syndrom, 10-20 years of age

The group is identified based on genetic testing either prenatal or postnatal

Eligibility Criteria

Age10 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All persons with Downs syndrom in the relevant agegroup living in Denmark will be invited to the study

You may qualify if:

  • genetic diagnosis of trisomi 21 / downs syndrome

You may not qualify if:

  • inability to have cornea tomography performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, 8200, Denmark

Location

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • Sashia Bennett, MD, PhD

    University of Aarhus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2026

First Posted

September 2, 2026

Study Start

September 15, 2025

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

September 2, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

We are not allowed to shared data on an individual level as per our ethical permission

Locations